Literature DB >> 28651463

[What do family medicine trainees think about gratitude payment?]

Zsuzsa Győrffy1, László Kalabay2, András Mohos3, Bernadett Márkus2, Anna Nánási4, József Rinfel5, Edmond Girasek6, Péter Torzsa2.   

Abstract

INTRODUCTION: The issue of gratuity is one of the most important health policy issues in Hungary. AIM: The authors' aim is to investigate the attitude of Hungarian family medicine trainees towards gratitude payment.
METHOD: Quantitative, paper-based survey among trainees from four Departments of Family Medicine in Hungary (n = 152).
RESULTS: More than 50 percent of the residents do not approve of accepting gratitude money. Men (p<0.026), and graduating residents accept it significantly more often (p<0.036) while doctors with children tend to accept it more frequently (p<0.051). They think that the reason for this phenomenon is the lack of proper care (65%), vulnerability and the sense of real gratitude patients feel (52%). According to the participants, the least influencing factor was the low salary of physicians (14.4%). They believe that accepting gratuity is a corruption, and it's humiliating for doctors (80-80%).
CONCLUSION: Family medicine residents approve of gratitude money even less as compared to the results of previous studies, but related to other gratitude payment issues we have found similar opinions. Orv Hetil. 2017; 158(26): 1028-1035.

Entities:  

Keywords:  Central and Eastern Europe; Kelet-Közép-Európa; alapellátás; családorvos-rezidens; family medicine trainees; gratitude payment; hálapénz; primary care

Mesh:

Year:  2017        PMID: 28651463     DOI: 10.1556/650.2017.30768

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

1.  Primary care behind the former "Iron Curtain": changes and development of primary healthcare provision in the Eastern part of the European Union.

Authors:  Csilla Semánová; Sarolta E Rurik; Csaba Dózsa; Zoltán Jancsó; László R Kolozsvári; Anna Nánási; Markéta Pfeiferová; Imre Rurik
Journal:  Prim Health Care Res Dev       Date:  2019-09-09       Impact factor: 1.458

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.